科华生物：控股子公司的基孔肯雅热病毒RNA检测试剂盒未申请医疗器械注册证

Group 1 - The company’s subsidiary, Xi'an Tianlong, has not applied for the National Medical Products Administration (NMPA) medical device registration certificate for its Chikungunya virus RNA detection kit (fluorescent PCR method) [2] - The detection kit is currently only available as a research reagent and is suitable for testing needs in customs and disease control scenarios [2] - The company will closely monitor market demand and will formulate product registration plans based on actual business needs and development strategies to actively seize related business opportunities [2]